PN

Perumalsamy Nirmala

Active Director Director DIN 01831976
DIN 01831976 First appointment Oct 1998 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Oct 1998
Shareholding value •••• Premium profile

About Perumalsamy Nirmala

Data last updated:

Perumalsamy Nirmala is a Director at Appasamy Medical Equipments Private Limited (since 1998), Director at Eye Photonics (India) Private Limited (since 2003) and Designated Partner at Janapriya Opticals Llp (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Consumer Products and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.11 Cr; the largest is Appasamy Medical Equipments Private Limited at ₹5.10 Cr (FY 2024). Earlier, Perumalsamy Nirmala was a Director at Appasamy Associates Private Limited (2019–2024).

DIN 01831976
Primary Designation Director
Industry Healthcare
First Appointment 30 Oct 1998
Oldest Company Age 31 yrs
Largest company Appasamy Medical Equipments Private Limited · ₹5.10 Cr (FY 2024)
Combined revenue ₹5.11 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 19981995₹5.10 Cr (FY 2024)Active
Director11 Apr 20032003₹53,744 (FY 2024)Active
Designated Partner05 Feb 20252025Active
Aa Biologics Private Limited U24290TN2022PTC148965
Director19 Jul 20242022Active
Aec Pharmacy Llp ACD-5326
Designated Partner01 Apr 20242023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Appasamy Associates Private Limited U33201TN2019PTC129614
Director29 May 20192019₹1,014 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Appasamy Medical Equipments Private Limited
Eye Photonics (India) Private Limited
Aa Biologics Private Limited
Janapriya Opticals Llp
Premium access

Shareholding and investment profile for Perumalsamy Nirmala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Perumalsamy Nirmala

Perumalsamy Nirmala currently holds 5 directorships: Appasamy Medical Equipments Private Limited (Director, since 30 Oct 1998, revenue ₹5.10 Cr (FY 2024)); Eye Photonics (India) Private Limited (Director, since 11 Apr 2003, revenue ₹53,744 (FY 2024)); Janapriya Opticals Llp (Designated Partner, since 05 Feb 2025); Aa Biologics Private Limited (Director, since 19 Jul 2024); Aec Pharmacy Llp (Designated Partner, since 01 Apr 2024).

Perumalsamy Nirmala was first appointed on 30 Oct 1998 as Director at Appasamy Medical Equipments Private Limited. The most recent appointment on record is 05 Feb 2025 at Janapriya Opticals Llp.

The 2 current companies of Perumalsamy Nirmala that report revenue have a combined latest revenue of ₹5.11 Cr: Appasamy Medical Equipments Private Limited ₹5.10 Cr (FY 2024); Eye Photonics (India) Private Limited ₹53,744 (FY 2024).

Perumalsamy Nirmala held 1 earlier board appointment: Appasamy Associates Private Limited (Director, 29 May 2019 to 05 Apr 2024).

The current boards of Perumalsamy Nirmala's companies include Ravilla Narayanasamy Meera (Appasamy Medical Equipments Private Limited), Leela Srinivasan (Eye Photonics (India) Private Limited), Rajeswari Ravilla Venkadasalaappasa (Eye Photonics (India) Private Limited), Ramamoorthy Krishnaveni (Eye Photonics (India) Private Limited), Susila (Eye Photonics (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available